Related Experiment Video
Updated: Apr 18, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Improving the diagnostic accuracy for detecting cardiac sarcoidosis
Eleanor C Wicks1, Leon J Menezes, Perry M Elliott
1The Heart Hospital, 16-18 Westmoreland Street, London, W1G 8PH, UK.
Insights
Cardiac sarcoidosis (CS) is often underdiagnosed, despite its potential to cause fatal heart conditions. This review examines how advanced imaging techniques can improve the detection and management of CS.
Area of Science:
- Cardiology
- Immunology
- Medical Imaging
Background:
- Cardiac sarcoidosis (CS) is a severe manifestation of systemic sarcoidosis.
- Clinical evidence of CS is found in only 5% of patients, but autopsy studies reveal a prevalence as high as 79%, indicating significant underdiagnosis.
- Current diagnostic and therapeutic strategies for CS lack consensus, posing challenges in clinical practice.
Purpose of the Study:
- To explore the impact of novel diagnostic strategies on improving the accuracy of CS detection.
- To review advancements in multimodality imaging for diagnosing and monitoring cardiac sarcoidosis.
- To address the diagnostic and therapeutic challenges associated with underdiagnosed CS.
Main Methods:
- Review of existing literature on cardiac sarcoidosis.
- Exploration of multimodality imaging techniques (e.g., cardiac MRI, PET scans).
- Analysis of diagnostic accuracy and treatment monitoring strategies.
Main Results:
- Autopsy studies suggest a much higher prevalence of CS than clinically diagnosed cases.
- Multimodality imaging offers potential for enhanced diagnostic accuracy in detecting CS.
- Novel imaging strategies may aid in earlier detection and more effective management of CS.
Conclusions:
- Cardiac sarcoidosis is significantly underdiagnosed, leading to potential delays in treatment.
- Advanced imaging techniques are crucial for improving the detection and management of CS.
- Further research and consensus are needed to optimize the diagnosis and treatment of this condition.
Abstract:
Cardiac sarcoid is a potentially fatal condition that presents with a wide range of clinical manifestations including conduction abnormalities, tachyarrhythmias, congestive heart failure, cardiomyopathy and sudden cardiac death. Small observational registries and non-comparative studies have described clinical evidence of cardiac involvement in 5% of patients with systemic sarcoid, yet autopsy studies suggest prevalence as high as 79%. This suggests that cardiac sarcoidosis (CS) is underdiagnosed in everyday clinical practice. The scarcity of data and lack of consensus on the most appropriate methods for detecting, monitoring and treating CS presents a significant diagnostic and therapeutic challenge. This review explores the potential impact of novel strategies, including multimodality imaging, on the diagnostic accuracy for detecting CS and treatment.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pericarditis II: Clinical Features and Diagnostic Tests

